Br J Sports Med. Published Online First: 24 October 2006. doi:10.1136/bjsm.2006.030643
Tendinopathies issue |
Tissue engineering for tendon repair
1 Institute of Science and Technology in Medicine, Keele University, United Kingdom
2 Keele University School of Medicine, United Kingdom
* To whom correspondence should be addressed. E-mail: osa14{at}keele.ac.uk.
Accepted 22 September 2006
Abstract
Tissue engineering aims to induce tissue self- regeneration in vivo or to produce a functional tissue replacement in vitro to be then implanted in the body. To produce a viable and functional tendon, the generation of a uniaxially orientated collagen type I matrix is required. Biochemical and physical factors can potentially alter both the production and the organization of this matrix, and their combination in a dose and time-dependent manner is probably the key to in vitro engineered tendons. This review discusses the role of these different factors affecting tenocytes growth in three-dimensional environment in vivo and in vitro, and underlines the future challenge of tendon tissue engineering.
Key Words: growth factors, mechanical stimuli, scaffolds, tendon tissue engineering, tenocytes
This article has been cited by other articles:
-
Maffulli, N., Longo, U. G.
(2008). Conservative management for tendinopathy: is there enough scientific evidence?. Rheumatology (Oxford)
47: 390-391
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
